[Degeneration of a congenital pulmonary adenomatoid cyst and ventricular trigeminism of adulte age. Is there a cause-and-effect relationship?] In french.
JP. Salmon, V. Corbion-Jossa, M. Guiot-Ramaut
Rev.Pneumol.Clin., 1997,
53, 33-36.
Delayed massive immune hemolysis mediated by minor ABO incompatibility after
allogeneic peripheral blood stem cell transplantation.
JP. Salmon, S. Michaux, J-Ph. Hermanne, E. Baudoux, Ch. Gérard, D. Sondag-Thull, G. Fillet, Y. Beguin
Transfusion, 1998,
39, 824-827.
Clinical course and predictive factors for Cyclosporine - induced autologous graft - versus - host disease after autologous hematopoietic stem cell transplatation (HSCT).
F. Baron, A. Gothot, JP. Salmon, J-Ph. Hermanne, G.E. Pierard, G. Fillet, Y. Beguin
Br J Haematol, 2000 Dec,
111 (3); 745-753.
Administration of rHuEPO and G-CSF in donor / recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogenic PBPC transplantation.
Brieux Sautois*, Etienne Baudoux°, Jean Paul Salmon*, Sandrine Michaux*, Nicole Schaaf-Lafontaine
#, Maguy Pereira*, Jean-Michel Paulus
#, Georges Fillet*, Yves Beguin*. Department of Medecine, Division of Haematology, Department of Transfusion Medecine, Department of Clinical Biology Division of Laboratory Haematology
#, University of Liège, Liège, Belgium
Haematologica, 2001,
86, 1209-1218.
Sequencial Administration of Epirubicin and Paclitaxel for Advanced Breast Cancer.A Phase I Randomized Trial.
C. Focan, MP Graas, M. Bauduin, J-L. Canon, JP. Salmon, G. Jerusalem, D. Focan- Henrard, JP. Lobelle and D. Schallier
Anticancer research, 2005,
25, 1211-1218
.
Increased iron absorption during autologous blood donation supported by recombinant
human erythropoietin therapy.
C.Bovy, E. Baudoux, JP. Salmon, Y. Beguin
Transfusion, 2006,
46, 1616-1623.
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal
women with breast cancer (SOLE): A multicentre, open-label, randomised, phase 3 trial
Marco Colleoni,
Weixiu Luo, Per Karlsson, all 252 authors
The Lancet Oncology, November 2017
10.1016/S1470-2045(17)30715-5
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast
cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled,
phase 3 trial.
Miguel Martin,Frankie Ann Holmes,
Bent Ejlertsen, all 622 authors, Mahmoud Charif
The Lancet Oncology, November 2017
10.1016/S1470-2045(17)30717-9
Febrile neutropenia (FN) and pegfilgrastim prophylaxis in breast cancer and non-Hodgkin's lymphoma patients receiving high (>20%) FN-risk chemotherapy:
results from a prospective observational study.
Jean Paul Salmon
1, Martin Smakal
2, Charisios Karanikiotis
3, Marek Z.
Wojtukiewicz
4, Yohann Omnes
5, Lucy DeCosta
5, Sally Wetten
6, James O’Kelly
6
1Centre Hospitalier Régional de la Citadelle, Medical Oncology, Liège, Belgium ;
2Nemocnice Hořovice Hospital, Hořovice, Czech Republic; 3424 Army General
Hospital, Thessaloniki, Greece;
4Medical University, Comprehensive Cancer Center,
Bialystok, Poland;
5Amgen Biostatistical Sciences, Uxbridge, UK;
6Amgen Center for
Observational Research, Uxbridge, UK.
Supportive Care in Cancer, 26 09 2018, 1-9
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment
Guillon Jordan, Petit Coralie, Moreau Marie, Bertrand Toutain, Roché Henri,
Bonichon-Lamichhane Nathalie, Salmon JP, Lemonnier Jérôme, Campone Mario,
Verrièle Véronique, Lelièvre Eric, Guette Catherine and Coqueret Olivier
Cell death and desease, feb 2019 10 ;199
Prise en charge d’un myélome multiple chez une patiente âgée aux antécédents de néoplasie mammaire : illustration de l’intérêt d’une collaboration multidisciplinaire.
A multiple myeloma in an elderly patient with a history of breast cancer: illustration of
the value of multidisciplinary collaboration
Legros M, Bouillon AS, Janin N, Moonen M, Louviaux I, Salmon JP, Berg N, Servais P
Revue Médicale de Liège, Avril 2021